Search Results - "Houston, Fraser E."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction

    Prevention of Doxorubicin-Induced Autophagy Attenuates Oxidative Stress and Skeletal Muscle Dysfunction by Doerr, Vivian, Montalvo, Ryan N, Kwon, Oh Sung, Talbert, Erin E, Hain, Brian A, Houston, Fraser E, Smuder, Ashley J

    Published in Antioxidants (23-03-2020)
    “…Clinical use of the chemotherapeutic doxorubicin (DOX) promotes skeletal muscle atrophy and weakness, adversely affecting patient mobility and strength…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Influence of a caffeine mouth rinse on sprint cycling following glycogen depletion

    Influence of a caffeine mouth rinse on sprint cycling following glycogen depletion by Kizzi, Joseph, Sum, Alvin, Houston, Fraser E., Hayes, Lawrence D.

    Published in European journal of sport science (16-11-2016)
    “…Attenuated performance during intense exercise with limited endogenous carbohydrate (CHO) is well documented. Therefore, this study examined whether caffeine…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle

    Inhibition of the proteasome partially attenuates atrophy in botulinum neurotoxin treated skeletal muscle by Houston, Fraser E., Hain, Brian A., Dodd, Stephen L.

    Published in Toxicon (Oxford) (15-03-2018)
    “…Botulinum neurotoxin type A (BoNT/A) is used as a therapeutic tool to induce chemical denervation of spastically contracted muscles, yet the neurotoxin can…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle

    Heat shock protein 70 overexpression does not attenuate atrophy in botulinum neurotoxin type A-treated skeletal muscle by Houston, Fraser E, Hain, Brian A, Adams, Thomas J, Houston, Kati L, O'Keeffe, Roderic, Dodd, Stephen L

    Published in Journal of applied physiology (1985) (01-07-2015)
    “…Botulinum neurotoxin type A (BoNT/A) is used clinically to induce therapeutic chemical denervation of spastically contracted skeletal muscles. However, BoNT/A…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    Autophagy promotes cancer chemotherapy‐induced oxidative stress and skeletal muscle dysfunction

    Autophagy promotes cancer chemotherapy‐induced oxidative stress and skeletal muscle dysfunction by Smuder, Ashley J., Kwon, Oh Sung, Hain, Brian A., Houston, Fraser E., Talbert, Erin E.

    Published in The FASEB journal (01-04-2018)
    “…Chemotherapy‐induced cachexia is a debilitating condition characterized by fatigue and muscle wasting. The onset of muscle weakness in patients often limits…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  6. 6
    Botulinum Neurotoxin Type A Induces Skeletal Muscle Atrophy Without Altering Heat Shock Protein 70 Expression

    Botulinum Neurotoxin Type A Induces Skeletal Muscle Atrophy Without Altering Heat Shock Protein 70 Expression by Hain, Brian A., Houston, Fraser E., Mann, James R., Dodd, Stephen L.

    Get full text
    Journal Article
    Save to List
    Saved in:
  7. 7
    Proteolytic mechanisms of botulinum neurotoxin type A-induced skeletal muscle atrophy

    Proteolytic mechanisms of botulinum neurotoxin type A-induced skeletal muscle atrophy by Houston, Fraser E

    Published 01-01-2015
    “…Our previous research suggests that the mechanism of botulinum neurotoxin-type A (BoNT/A)-induced atrophy does not occur via a NF-κB/Foxo-dependent or…”
    Get full text
    Dissertation
    Save to List
    Saved in:

Search Tools: